within Pharmacolibrary.Drugs.ATC.N;

model N05AF04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 20 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.017,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tiotixene is a typical antipsychotic medication of the thioxanthene class, primarily used in the management of schizophrenia. It works mainly as a dopamine D2 receptor antagonist, with some activity as an antagonist at other receptors such as serotonin and histamine. Tiotixene has been used since the 1960s and is still approved for antipsychotic therapy in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adults with schizophrenia (typical clinical population), as no direct published PK study data are available.</p><h4>References</h4><ol><li><p>Heel, RC, et al., &amp; Avery, GS (1978). Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. <i>Drugs</i> 15(3) 198–217. DOI:<a href=&quot;https://doi.org/10.2165/00003495-197815030-00002&quot;>10.2165/00003495-197815030-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25167/&quot;>https://pubmed.ncbi.nlm.nih.gov/25167</a></p></li><li><p>Menuck, M, &amp; Voineskos, G (1981). Rapid parenteral treatment of acute psychosis. <i>Comprehensive psychiatry</i> 22(4) 351–361. DOI:<a href=&quot;https://doi.org/10.1016/0010-440x(81)90018-3&quot;>10.1016/0010-440x(81)90018-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6114808/&quot;>https://pubmed.ncbi.nlm.nih.gov/6114808</a></p></li><li><p>Hobbs, DC, et al., &amp; Van der Velde, CD (1974). Pharmacokinetics of thiothixene in man. <i>Clinical pharmacology and therapeutics</i> 16(3) 473–478. DOI:<a href=&quot;https://doi.org/10.1002/cpt1974163part1473&quot;>10.1002/cpt1974163part1473</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4415039/&quot;>https://pubmed.ncbi.nlm.nih.gov/4415039</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05AF04;
